ADAP

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Adaptimmune Therapeutics (ADAP) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ADAP is expected to report earnings to rise 197.00% to -2 cents per share on February 27

Adaptimmune Therapeutics ADAP Stock Earnings Reports

Q4'24

Est.

$-0.03

Q3'24

Est.

$-0.01

Q2'24

Beat

by $0.09

Q1'24

Beat

by $0.12

Q4'23

Beat

by $0.13

The last earnings report on November 13 showed earnings per share of 0 cents, meeting the estimate of 0 cents. With 621.59K shares outstanding, the current market capitalization sits at 148.39M.

View a ticker or compare two or three

Compare

ADAP

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ADAP
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a manufacturer of vaccines and cancer immunotherapy products

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

60 Jubilee Avenue

Phone

+44 1235430000

Employees

449

Web

https://www.adaptimmune.com